Ironwood Pharmaceuticals, Inc. (IRWD) - Stock Prices, Stock Peers & Analysis

Home
IRWD

Company Name	Ironwood Pharmaceuticals, Inc.
Symbol	IRWD
Currency	USD
Price	0.709
Market Cap Market Cap The market capitalization (market cap) of a stock represents the total market value of a company's outstanding shares of stock. It's a key metric used to gauge a company's size and investment risk, and it can be an important factor in investment decisions. Here's how it's calculated: Market Cap = Number of Outstanding Shares × Current Share Price	114,754,943
Dividend Yield Dividend Yield The dividend yield is a financial ratio that measures the amount of cash dividends distributed to common shareholders relative to the market value per share. The dividend yield is represented as a percentage and can be calculated by dividing the dollar value of dividends paid in a given year per share of stock held by the dollar value of one share of stock. Here's how it's calculated: Dividend Yield = Annual Dividends per Share / Price per Share	0%
52-week-range	0.59 - 7.22
Industry	Drug Manufacturers—Specialty & Generic
Sector	Healthcare
CEO	Mr. Thomas A. McCourt
Website	https://www.ironwoodpharma.com

An error occurred while fetching data.

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZESS name in the United States